145 related articles for article (PubMed ID: 1763893)
1. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects.
Arai H; Lee VM; Messinger ML; Greenberg BD; Lowery DE; Trojanowski JQ
Ann Neurol; 1991 Nov; 30(5):686-93. PubMed ID: 1763893
[TBL] [Abstract][Full Text] [Related]
2. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
[TBL] [Abstract][Full Text] [Related]
3. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls.
Tagliavini F; Ghiso J; Timmers WF; Giaccone G; Bugiani O; Frangione B
Lab Invest; 1990 Jun; 62(6):761-7. PubMed ID: 2113597
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
6. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
7. Differential distribution of Alzheimer's amyloid precursor protein family variants in human sperm.
Fardilha M; Vieira SI; Barros A; Sousa M; Da Cruz e Silva OA; Da Cruz e Silva EF
Ann N Y Acad Sci; 2007 Jan; 1096():196-206. PubMed ID: 17405931
[TBL] [Abstract][Full Text] [Related]
8. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
9. [Expression of amyloid beta-protein gene in Alzheimer's disease].
Tanaka S; Nakamura S; Ueda K
Rinsho Byori; 1990 May; 38(5):489-93. PubMed ID: 2116540
[TBL] [Abstract][Full Text] [Related]
10. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
Kawabata S; Higgins GA; Gordon JW
Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
[TBL] [Abstract][Full Text] [Related]
11. Heat shock alters Alzheimer's beta amyloid precursor protein expression in human endothelial cells.
Ciallella JR; Rangnekar VV; McGillis JP
J Neurosci Res; 1994 Apr; 37(6):769-76. PubMed ID: 8046777
[TBL] [Abstract][Full Text] [Related]
12. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
13. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
[TBL] [Abstract][Full Text] [Related]
14. Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls.
Sun A; Koelsch G; Tang J; Bing G
Exp Neurol; 2002 May; 175(1):10-22. PubMed ID: 12009756
[TBL] [Abstract][Full Text] [Related]
15. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
16. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
Suzuki T; Araki Y; Yamamoto T; Nakaya T
J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
[TBL] [Abstract][Full Text] [Related]
18. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
Kulnane LS; Lamb BT
Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
